bucladesine has been researched along with u 69593 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Allen, CN; Grandy, DK; Ikeda, M; Nelson, CS; Shinagawa, H; Shinoe, T; Sugiyama, T; Yoshioka, T | 1 |
1 other study(ies) available for bucladesine and u 69593
Article | Year |
---|---|
Cyclic AMP regulates the calcium transients released from IP(3)-sensitive stores by activation of rat kappa-opioid receptors expressed in CHO cells.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; 8-Bromo Cyclic Adenosine Monophosphate; Analgesics; Analgesics, Non-Narcotic; Analgesics, Opioid; Animals; Benzeneacetamides; Bucladesine; Calcium; Calcium Signaling; CHO Cells; Cloning, Molecular; Colforsin; Cricetinae; Cyclic AMP; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalin, D-Penicillamine (2,5)-; Enzyme Inhibitors; Gene Expression; Inositol 1,4,5-Trisphosphate; Peptides; Pyrrolidines; Rats; Receptors, Opioid, kappa; Thionucleotides; Transfection | 2001 |